Burden of chronic obstructive pulmonary disease in medicare beneficiaries residing in long-term care facilities

American Journal Geriatric Pharmacotherapy

Volumn 7, Issue 5, 2009, Pages 262-270

  Simoni Wastila, Linda ^a   Blanchette, Christopher M ^b,c   Qian, Jingjing ^a   Yang, Hui wen Keri ^a   Zhao, Lirong ^a   Zuckerman, Ilene H ^a   Pak, Grace H ^a   Silver, Harris ^b   Dalal, Anand A ^d  

^a UNIVERSITY OF MARYLAND SCHOOL OF PHARMACY   (United States)

^b LOVELACE RESPIRATORY RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF NORTH CAROLINA   (United States)

^d GLAXOSMITHKLINE   (United States)

Author keywords

burden; chronic obstructive pulmonary disease; cost; hospitalization; long term care

Indexed keywords

ANTIBIOTIC AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CEPHALOSPORIN DERIVATIVE; CORTICOSTEROID; COTRIMOXAZOLE; FLUTICASONE PROPIONATE PLUS SALMETEROL; IPRATROPIUM BROMIDE; IPRATROPIUM BROMIDE PLUS SALBUTAMOL SULFATE; LEUKOTRIENE RECEPTOR BLOCKING AGENT; LINCOMYCIN; MACROLIDE; PENICILLIN DERIVATIVE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SHORT ACTING DRUG; TETRACYCLINE DERIVATIVE; THEOPHYLLINE; TIOTROPIUM BROMIDE; XANTHINE DERIVATIVE;

AGE; AGED; ARTICLE; ASTHMA; CAUCASIAN; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; EMERGENCY CARE; FEMALE; HEALTH CARE COST; HEALTH CARE UTILIZATION; HOSPITAL COST; HOSPITALIZATION; HUMAN; LUNG INFECTION; MAJOR CLINICAL STUDY; MALE; MEDICAID; MEDICARE; NURSING HOME; PRIORITY JOURNAL; RACE DIFFERENCE; RESIDENTIAL CARE; RETROSPECTIVE STUDY; UNITED STATES;

AGE FACTORS; AGED; AGED, 80 AND OVER; ASTHMA; BRONCHODILATOR AGENTS; COHORT STUDIES; COST OF ILLNESS; COSTS AND COST ANALYSIS; DATABASES, FACTUAL; DRUG COSTS; EMERGENCY SERVICE, HOSPITAL; FEMALE; HOSPITALIZATION; HUMANS; LONG-TERM CARE; MALE; MEDICARE; MIDDLE AGED; NURSING HOMES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RETROSPECTIVE STUDIES; UNITED STATES;

EID: 71749107332     PISSN: 15435946     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjopharm.2009.11.003     Document Type: Article

References (40)

1. Murray C.J., and Lopez A.D. Evidence-based health policy-lessons from the Global Burden of Disease Study. Science. 274 (1996) 740-743
2. Mannino D.M., Homa D.M., Akinbami L.J., et al. Chronic obstructive pulmonary disease surveillance-United States, 1971-2000. MMWR Surveill Summ. 51 (2002) 1-16
3. Wouters E.F. Economic analysis of the Confronting COPD survey: An overview of results. Respir Med. 97 Suppl C (2003) S3-S14
4. American Lung Association. Epidemiology & statistics unit, research and program services. Trends in chronic obstructive bronchitis and emphysema. http://www.lungusa.org/atf/cf/7a8d42c2-fcca-4604-8ade-7f5d5e762256/COPD_DEC07.PDF Accessed May 14, 2009
5. Stewart A.L., Greenfield S., Hays R.D., et al. Functional status and well-being of patients with chronic conditions. Results from the Medical Outcomes Study [published correction appears in JAMA. 1989;262:2542]. JAMA 262 (1989) 907-913
6. Fried T.R., Pollack D.M., and Tinetti M.E. Factors associated with six-month mortality in recipients of community-based long-term care. J Am Geriatr Soc. 46 (1998) 193-197
7. Morbidity & Mortality: 2007 Chart Book on Cardiovascular, Lung, and Blood Diseases (2007), National Institutes of Health, National Heart, Lung, and Blood Institute. http://www.nhlbi.nih.gov/resources/docs/07-chtbk.pdf Accessed May 14, 2009
8. Grasso M.E., Weller W.E., Shaffer T.J., et al. Capitation, managed care, and chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 158 (1998) 133-138
9. Stuart B., Simoni-Wastila L., Zuckerman I.H., et al. Medication use by age and disabled Medicare beneficiaries across the spectrum of morbidity: A Chartbook. The Peter Lamy Center on Drug Therapy and Aging (2007), University of Maryland School of Pharmacy, Baltimore, Md. http://www.pharmacy.umaryland.edu/lamy/Chartbook.html Accessed May 14, 2009
10. Halpern M.T., Stanford R.H., and Borker R. The burden of COPD in the USA: Results from the Confronting COPD survey. Respir Med. 97 Suppl C (2003) S81-S89
11. Strassels S.A., Smith D.H., Sullivan S.D., and Mahajan P.S. The costs of treating COPD in the United States. Chest 119 (2001) 344-352
12. Sullivan S.D., Strassels S.A., and Smith D.H. Characterization of the costs of chronic obstructive pulmonary disease (COPD) in the US. Eur Respir J. 9 Suppl 23 (1996) 421S
13. Calverley P.M., Anderson J.A., Celli B., et al., TORCH Investigators. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med. 356 (2007) 775-789
14. Friedman M., and Hilleman D.E. Economic burden of chronic obstructive pulmonary disease. Impact of new treatment options. Pharmaco Economics. 19 (2001) 245-254
15. Niederman M.S., McCombs J.S., Unger A.N., et al. Treatment cost of acute exacerbations of chronic bronchitis. Clin Ther. 21 (1999) 576-591
16. Spence M.M., Hui R., and Chan J. Cost reduction strategies used by elderly patients with chronic obstructive pulmonary disease to cope with a generic-only pharmacy benefit. J Manag Care Pharm. 12 (2006) 377-382
17. Rascati K.L., Akazawa M., Johnsrud M., et al. Comparison of hospitalizations, emergency department visits, and costs in a historical cohort of Texas Medicaid patients with chronic obstructive pulmonary disease, by initial medication regimen. Clin Ther. 29 (2007) 1203-1213
18. Singh S., Loke Y.K., and Furberg C.D. Inhaled anticholinergics and risk of major adverse cardiovascular events in patients with chronic obstructive pulmonary disease: A systematic review and meta-analysis [published correction appears in JAMA. 2009;301:1227-1230]. JAMA 300 (2008) 1439-1450
19. Yohannes A.M., and Hardy C.C. Treatment of chronic obstructive pulmonary disease in older patients: A practical guide. Drugs Aging. 20 (2003) 209-228
20. Simoni-Wastila L., Yang H.K., Blanchette C.M., et al. Hospital and emergency department utilization associated with treatment for chronic obstructive pulmonary disease in a managed-care Medicare population. Curr Med Res Opin. 25 (2009) 2729-2735
21. American Medical Association (AMA). Current Procedural Terminology: 2001 (2000), AMA, Chicago, Ill
22. World Health Organization. International Statistical Classification of Diseases and Related Health Problems, Ninth Revision, Clinical Modification (2003), WHO, Geneva, Switzerland
23. Rabe K.F., Hurd S., Anzueto A., et al., Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 176 (2007) 532-555
24. Halbert R.J., Natoli J.L., Gano A., et al. Global burden of COPD: Systematic review and meta-analysis. Eur Respir J. 28 (2006) 523-532
25. Meyer P.A., Mannino D.M., Redd S.C., and Olson D.R. Characteristics of adults dying with COPD. Chest 122 (2002) 2003-2008
26. Mannino D.M., and Buist A.S. Global burden of COPD: Risk factors, prevalence, and future trends. Lancet 370 (2007) 765-773
27. Charlson M.E., Pompei P., Ales K.L., and MacKenzie C.R. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chronic Dis. 40 (1987) 373-383
28. Fruchter O., and Yigla M. Predictors of long-term survival in elderly patients hospitalized for acute exacerbations of chronic obstructive pulmonary disease. Respirology 13 (2008) 851-855
29. Centers for Medicare and Medicaid. Healthcare Common Procedure Coding System. http://www.cms.hhs.gov/HCPCSReleaseCodeSets/02_HCPCS_Quarterly_Update.asp Accessed October 29, 2009
30. Loeb M.B. Community-acquired pneumonia in older people: The need for a broader perspective. J Am Geriatr Soc. 51 (2003) 539-543
31. Medina-Walpole A.M., and Katz P.R. Nursing home-acquired pneumonia. J Am Geriatr Soc. 47 (1999) 1005-1015
32. Nicolle L.E. Infection control in long-term care facilities. Clin Infect Dis. 31 (2000) 752-756
33. Muder R.R. Pneumonia in residents of long-term care facilities: Epidemiology, etiology, management, and prevention. Am J Med. 105 (1998) 319-330
34. High K.P., Bradley S., Loeb M., et al. A new paradigm for clinical investigation of infectious syndromes in older adults: Assessment of functional status as a risk factor and outcome measure. Clin Infect Dis. 40 (2005) 114-122
35. Khanna K.V., and Markham R.B. A perspective on cellular immunity in the elderly. Clin Infect Dis. 28 (1999) 710-713
36. Cydulka R.K., McFadden Jr. E.R., Emerman C.L., et al. Patterns of hospitalization in elderly patients with asthma and chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 156 (1997) 1807-1812
37. Tinkelman D.G., George D., and Halbert R.J. Chronic obstructive pulmonary disease in patients under age 65: Utilization and costs from a managed care sample. J Occup Environ Med. 47 (2005) 1125-1130
38. CDC Nursing Home Facilities (December 2006). www.cdc.gov/nchs/data/nnhsd/nursinghomefacilities2006.pdf Accessed May 14, 2009
39. American Diabetes Association. Economic costs of diabetes in the US in 2007 [published correction appears in Diabetes Care. 2008;31:1271]. Diabetes Care 31 (2008) 596-615
40. Delea T.E., Hagiwara M., Dalal A.A., et al. Healthcare use and costs in patients with chronic bronchitis initiating maintenance therapy with fluticasone/salmeterol vs other inhaled maintenance therapies. Curr Med Res Opin 25 (2009) 1-13